At 8.3x earnings and 9.5x forward earnings, ACGL trades at a clear discount to what its 16.70% ROIC and 18.00% operating margin would normally command, suggesting the market is not pricing it as a high-quality compounder. The forward PEG of 0.7 reinforces the idea that growth is being undervalued relative to price. However, Return on Equity of just 4.00% tempers the enthusiasm, implying capital efficiency at the equity level is weaker than ROIC suggests. With no Altman Z-Score provided, balance sheet distress risk cannot be formally assessed here, but on pure earnings multiple and growth alignment, the stock screens as statistically cheap rather than expensive.